dichloroacetic acid has been researched along with Hypertrophy, Right Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Des Rosiers, C; Isern, NG; Kajimoto, M; Nuri, M; Portman, MA; Robillard-Frayne, I | 1 |
| Alavian, KN; Ashek, A; Bozorgi, S; Busbridge, M; Cotroneo, E; Dubois, O; Wang, L; Wharton, J; Wilkins, MR; Zhao, L | 1 |
| Bonnet, S; Dyck, JR; Haromy, A; Hashimoto, K; McMurtry, MS; Michelakis, ED; Wu, X | 1 |
3 other study(ies) available for dichloroacetic acid and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Metabolic Response to Stress by the Immature Right Ventricle Exposed to Chronic Pressure Overload.
Topics: Animals; Animals, Newborn; Dichloroacetic Acid; Disease Models, Animal; Energy Metabolism; Enzyme Activation; Enzyme Activators; Heart Ventricles; Hypertrophy, Right Ventricular; Ligation; Male; Pulmonary Artery; Pyruvate Dehydrogenase Complex; Sus scrofa; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2019 |
Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Benzamides; Cell Proliferation; Deficiency Diseases; Dichloroacetic Acid; Disease Models, Animal; Erythropoiesis; Ferric Compounds; Ferritins; Glycolysis; Hematinics; Homeostasis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imatinib Mesylate; Iron; Iron Deficiencies; Liver; Male; Maltose; Piperazines; Pulmonary Artery; Pyrimidines; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Transferrin; Vascular Remodeling | 2015 |
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
Topics: Animals; Apoptosis; Cell Division; Cells, Cultured; Dichloroacetic Acid; Drug Evaluation, Preclinical; Gene Expression Regulation; Heart Failure; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Kv1.5 Potassium Channel; Mitochondria; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Specificity; Oxidative Phosphorylation; Potassium Channels, Voltage-Gated; Pulmonary Artery; Rats; Shab Potassium Channels; Vascular Resistance | 2004 |